Michal Osuchowski

Rzeszow, PK 35959, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Assessment of T1 and T2 Relaxation-Time Changes in NMIBC Tissue After 5-ALA Photodynamic Therapy Using Quantitative Magnetic Resonance Imaging.

Assessment of T1 and T2 Relaxation-Time Changes in NMIBC Tissue After 5-ALA Photodynamic Therapy Using Quantitative Magnetic Resonance Imaging.

Journal: Biomedicines

Published: August 27, 2025

The Application of Surface Luminance Distribution Measurements to the Evaluation of Neoplastic Lesions of the Prostate Gland.

The Application of Surface Luminance Distribution Measurements to the Evaluation of Neoplastic Lesions of the Prostate Gland.

Journal: Cancers

Published: December 30, 2024

Advancements in photodynamic therapy of esophageal cancer.

Advancements in photodynamic therapy of esophageal cancer.

Journal: Frontiers in oncology

Published: August 23, 2022

An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.

An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.

Journal: International journal of molecular sciences

Published: July 26, 2022

Photodynamic Therapy-Adjunctive Therapy in the Treatment of Prostate Cancer.

Photodynamic Therapy-Adjunctive Therapy in the Treatment of Prostate Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: April 05, 2022

The Use of Upconversion Nanoparticles in Prostate Cancer Photodynamic Therapy.

The Use of Upconversion Nanoparticles in Prostate Cancer Photodynamic Therapy.

Journal: Life (Basel, Switzerland)

Published: February 28, 2021

Photodynamic therapy for prostate cancer - A narrative review.

Photodynamic therapy for prostate cancer - A narrative review.

Journal: Photodiagnosis and photodynamic therapy

Published: May 15, 2020

α4β7 Integrin Antagonist Vedolizumab for the Treatment of Refractory Ileitis.

α4β7 Integrin Antagonist Vedolizumab for the Treatment of Refractory Ileitis.

Journal: Case reports in gastrointestinal medicine

Published: November 21, 2018

Primary diffuse meningeal melanomatosis - a rare form of meningeal melanoma: case report.

Primary diffuse meningeal melanomatosis - a rare form of meningeal melanoma: case report.

Journal: BMC neurology

Published: September 12, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026